Table 2.

Standardised beta coefficients derived from separate multivariable linear regression models investigating the relationship between cardiometabolic and cardiovascular conditions and the Z-scored PHQ-9 results

	Standardised beta coefficient	95% CI	P value
Metabolic syndrome	−0.004	(−0.040 to 0.033)	0.847
Obesity	0.007	(−0.028 to 0.042)	0.680
Hypertriglyceridaemia	−0.006	(−0.040 to 0.029)	0.742
Reduced HDL cholesterol	−0.027	(−0.067 to 0.012)	0.177
Hypertension grade I	0.028	(−0.007 to 0.062)	0.113
FPG >100	−0.022	(−0.061 to 0.019)	0.298
Hypertension grade II	0.014	(−0.020 to 0.048)	0.427
Prediabetes	0.005	(−0.034 to 0.043)	0.819
Diabetes	−0.001	(−0.040 to 0.039)	0.972
Self-reported conditions
Hypertension	0.032	(−0.003 to 0.066)	0.071
Diabetes	0.004	(−0.029 to 0.038)	0.809
Heart disease	0.081	(0.047 to 0.114)	<0.001
Stroke	0.038	(0.005 to 0.071)	0.024
Self-reported stroke symptoms
Sudden drooping	0.090	(0.057 to 0.123)	<0.001
Sudden numbness	0.136	(0.102 to 0.168)	<0.001
Sudden slurring	0.144	(0.110 to 0.176)	<0.001
Self-reported metabolic syndrome	0.070	(0.035 to 0.104)	<0.001

Each standardised coefficient arises from a separate model controlling for age, sex, gender, place ofresidence, education, ethnicity and wealth quintile. The separate models can be found in (online supplemental tables 6-22).

FPG, fasting plasma glucose; HDL, high-density lipoprotein; PHQ-9, Patient Health Questionnaire depression module.